Managing pediatric tuberculosis (TB) remains a public health problem requiring urgent and
long-lasting solutions as TB is one of the top ten causes of ill health and death in children as …

The antimicrobial drugs currently used for the management of tuberculosis (TB) exhibit poor
bioavailability that necessitates prolonged treatment regimens and high dosing frequency to …

Background Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most
common form of drug resistance, and is associated with failure, relapse, and acquired …

In the last 5 years, childhood tuberculosis (TB) has received increasing attention from
international organisations, national TB programmes and academics. For the first time, a …

Drug-resistant tuberculosis (DR-TB) is still one of the most critical issues impeding
worldwide TB control efforts. The aim of this systematic review and meta-analysis was to …

Tuberculosis (TB) in children is a neglected aspect of the TB epidemic despite it constituting
20% or more of all TB cases in many countries with high TB incidence. Childhood TB is a …

Liposomes are reputed colloidal vehicles that hold the promise for targeted delivery of anti-
tubercular drugs (ATBDs) to alveolar macrophages that host Mycobacterium tuberculosis …

BACKGROUND: Isoniazid has been the backbone of tuberculosis chemotherapy for 6
decades. Resistance to isoniazid threatens the efficacy of treatment of tuberculosis disease …

Background Tuberculosis (TB) remains a major global health problem. The childhood
tuberculosis has some unique features different which makes the diagnosis more …

Background Drug-resistant tuberculosis and extrapulmonary tuberculosis are the world
major public health issues. Although some primary studies have been reported on the …